New treatment aims to stop dangerous transplant complication
NCT ID NCT03805789
Summary
This study is testing whether a protein called Alpha-1 Antitrypsin can prevent graft-versus-host disease (GVHD) in patients receiving stem cell transplants for blood cancers. GVHD is a serious complication where the donor's immune cells attack the patient's body. The trial involves 222 participants who will receive either the protein therapy or a placebo, alongside standard transplant care, to see if it reduces the risk of developing this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aichi Medical Center Nagoya Daiichi Hospital
Nagoya, 4538511, Japan
-
Anjo Kosei Hospital
Anjo-shi, 4668602, Japan
-
Ankara Abdurrahman Yurtaslan
Ankara, 06200, Turkey (Türkiye)
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Duke University Medical Center
Durham, North Carolina, 27705, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
-
Gachon University Gil Medical Center
Incheon, 21565, South Korea
-
Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli
Calabria, 89133, Italy
-
Hiroshima University Kasumi Campus
Hiroshima, 7348551, Japan
-
Hokkaido University Hospital
Sapporo, 0608648, Japan
-
HonorHealth Scottsdale Shea Medical Center
Scottsdale, Arizona, 85258, United States
-
Hospital Universitario Valle de Hebron
Barcelona, 08035, Spain
-
INJE University Haeundae Paik Hospital
Busan, 48108, South Korea
-
Johns Hopkins Hospital
St. Petersburg, Florida, 33701, United States
-
Marqués de Valdecilla University Hospital
Barcelona, 39008, Spain
-
Nagoya University Hospital
Nagoya, 4668550, Japan
-
Okayama University Hospital
Okayama, 71008558, Japan
-
Osaka International Cancer Institute
Osaka, 5418567, Japan
-
Osaka Metropolitan University Hospital
Osaka, 5458586, Japan
-
Pusan National University Hospital
Busan, 49241, South Korea
-
Royal Brisbane and Women's Hospital
Herston, Queenland, 4029, Australia
-
Salamanca University Hospital
Salamanca, 37007, Spain
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
The University of Texas-MD Anderson Cancer Center
San Antonio, Texas, 77030, United States
-
Tokyo Metropolitan Komagome Hospital
Bunkyō City, 1138677, Japan
-
Turgut Ozal Medicine Center
Battalgazi, 44280, Turkey (Türkiye)
-
Uniklinik Köln
Cologne, 50937, Germany
-
University Hospital Catania
Calabria, Catania, 95123, Italy
-
University Hospital Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of Kansas Cancer Center
Westwood, Kansas, 66205, United States
-
University of Michigan Medical Center
Ann Arbor, Michigan, 48109, United States
-
University of Utah Primary Children's Hospital
Salt Lake City, Utah, 84113, United States
-
University of Virginia Health System
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.